Pathophysiology of delirious states.

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Alcohol-induced delirium is a serious condition.
• Neurotransmitter systems, particularly noradrenergic (NA) pathways, are implicated in delirium.
• Understanding these changes is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of central noradrenergic activity in alcohol delirium.
• To examine the effects of clozapine on noradrenergic markers in both humans and rats.

Main Methods:

• Measured MHPG in CSF, urinary NA and A excretion, and serum DBH activity in patients during alcohol delirium and recovery.
• Administered single and repeated doses of clozapine to rats and measured MHPG in brain.
• Assessed clozapine's effect on urinary NA and A excretion in humans.

Main Results:

• Elevated MHPG, urinary NA and A, and serum DBH during alcohol delirium compared to recovery.
• No consistent changes in urinary DA and CSF HVA.
• Single clozapine dose increased urinary NA and A excretion.
• Repeated clozapine administration in rats initially increased MHPG, followed by a decrease.
• Clozapine treatment in humans decreased MHPG in CSF.

Conclusions:

• Alcohol delirium is associated with increased central noradrenergic (NA) turnover.
• Clozapine exhibits a time-dependent effect on NA markers.
• Findings suggest a potential therapeutic link between clozapine and managing delirium through modulation of NA pathways.